# FORDOZ PHARMA CORPORATION – FDA Inspection, Mar 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/fordoz-pharma-corporation/00df13bf-d33e-4cb4-9e1d-9e893134df59
Source feed: FDA_Inspections

> FDA inspection 1201660 of FORDOZ PHARMA CORPORATION, March 17, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201660
- Company Name: FORDOZ PHARMA CORPORATION
- Inspection Date: 2023-03-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1291050 - 2025-11-12](https://www.keypedia.com/records/fda_inspections/fordoz-pharma-corporation/f74f11d4-45af-4ab0-a6c7-ad42a05f6193)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)
- [FDA Associated Person](https://www.keypedia.com/people/pushpa-s-jayasekara/cfd7d22f-b4c2-4002-ae18-b5435815d27d)

Company: https://www.keypedia.com/companies/fordoz-pharma-corporation/d5bae860-733e-4866-86c1-e97c3087f8af

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248